Cargando…
CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review
BACKGROUND: Many studies have examined the association between the CYP1A1 MspI and exon 7 gene polymorphisms and lung cancer risk in various populations, but their results have been inconsistent. METHODS: To assess this relationship more precisely, a meta-analysis and review were performed. The PubM...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212928/ https://www.ncbi.nlm.nih.gov/pubmed/22014025 http://dx.doi.org/10.1186/1756-9966-30-99 |
_version_ | 1782216047745564672 |
---|---|
author | Zhan, Ping Wang, Qin Qian, Qian Wei, Shu-Zhen Yu, Li-Ke |
author_facet | Zhan, Ping Wang, Qin Qian, Qian Wei, Shu-Zhen Yu, Li-Ke |
author_sort | Zhan, Ping |
collection | PubMed |
description | BACKGROUND: Many studies have examined the association between the CYP1A1 MspI and exon 7 gene polymorphisms and lung cancer risk in various populations, but their results have been inconsistent. METHODS: To assess this relationship more precisely, a meta-analysis and review were performed. The PubMed, Embase, Web of Science, and CNKI database was searched for case-control studies published up to June 2010. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated. RESULTS: Ultimately, 64 studies, comprising 18,397 subjects from 49 case-control studies of the MspI genotype and 18,518 patients from 40 case-control studies of the exon 7 genotype, were included. A significantly elevated lung cancer risk was associated with 2 MspI genotype variants (for type C vs Type A: OR = 1.26, 95% CI = 1.12-1.42; for types B and C combined vs Type A: OR = 1.20, 95% CI = 1.13-1.28) in overall population. In the stratified analysis, a significant association was found in Asians, Caucasians, lung SCC, lung AC and Male population, not in mixed population, lung SCLC and Female population. However, inconsistent results were observed for CYP1A1 exon7 in our meta-analysis, two variants of the exon 7 polymorphism were associated with a significantly higher risk for lung cancer (for Val/Val vs Ile/Ile: OR = 1.24, 95% CI = 1.09-1.42; for (Ile/Val +Val/Val) vs Ile/Ile: OR = 1.15, 95% CI = 1.07-1.24) in overall population. In the stratified analysis, a significant assocation was found in Asians, Caucasians, lung SCC and Female population, not in mixed population, lung AD, lung SCLC and Male population. Additionally, a significant association was found in smoker population and not found in non-smoker populations for CYP1A1 MspI and exon7 gene. CONCLUSIONS: This meta-analysis suggests that the MspI and exon 7 polymorphisms of CYP1A1 correlate with increased lung cancer susceptibility and there is an interaction between two genotypes of CYP1A1 polymorphism and smoking, but these associations vary in different ethnic populations, histological types of lung caner and gender of case and control population. |
format | Online Article Text |
id | pubmed-3212928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32129282011-11-11 CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review Zhan, Ping Wang, Qin Qian, Qian Wei, Shu-Zhen Yu, Li-Ke J Exp Clin Cancer Res Research BACKGROUND: Many studies have examined the association between the CYP1A1 MspI and exon 7 gene polymorphisms and lung cancer risk in various populations, but their results have been inconsistent. METHODS: To assess this relationship more precisely, a meta-analysis and review were performed. The PubMed, Embase, Web of Science, and CNKI database was searched for case-control studies published up to June 2010. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated. RESULTS: Ultimately, 64 studies, comprising 18,397 subjects from 49 case-control studies of the MspI genotype and 18,518 patients from 40 case-control studies of the exon 7 genotype, were included. A significantly elevated lung cancer risk was associated with 2 MspI genotype variants (for type C vs Type A: OR = 1.26, 95% CI = 1.12-1.42; for types B and C combined vs Type A: OR = 1.20, 95% CI = 1.13-1.28) in overall population. In the stratified analysis, a significant association was found in Asians, Caucasians, lung SCC, lung AC and Male population, not in mixed population, lung SCLC and Female population. However, inconsistent results were observed for CYP1A1 exon7 in our meta-analysis, two variants of the exon 7 polymorphism were associated with a significantly higher risk for lung cancer (for Val/Val vs Ile/Ile: OR = 1.24, 95% CI = 1.09-1.42; for (Ile/Val +Val/Val) vs Ile/Ile: OR = 1.15, 95% CI = 1.07-1.24) in overall population. In the stratified analysis, a significant assocation was found in Asians, Caucasians, lung SCC and Female population, not in mixed population, lung AD, lung SCLC and Male population. Additionally, a significant association was found in smoker population and not found in non-smoker populations for CYP1A1 MspI and exon7 gene. CONCLUSIONS: This meta-analysis suggests that the MspI and exon 7 polymorphisms of CYP1A1 correlate with increased lung cancer susceptibility and there is an interaction between two genotypes of CYP1A1 polymorphism and smoking, but these associations vary in different ethnic populations, histological types of lung caner and gender of case and control population. BioMed Central 2011-10-20 /pmc/articles/PMC3212928/ /pubmed/22014025 http://dx.doi.org/10.1186/1756-9966-30-99 Text en Copyright ©2011 Zhan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Zhan, Ping Wang, Qin Qian, Qian Wei, Shu-Zhen Yu, Li-Ke CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review |
title | CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review |
title_full | CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review |
title_fullStr | CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review |
title_full_unstemmed | CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review |
title_short | CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: An updated meta-analysis and review |
title_sort | cyp1a1 mspi and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212928/ https://www.ncbi.nlm.nih.gov/pubmed/22014025 http://dx.doi.org/10.1186/1756-9966-30-99 |
work_keys_str_mv | AT zhanping cyp1a1mspiandexon7genepolymorphismsandlungcancerriskanupdatedmetaanalysisandreview AT wangqin cyp1a1mspiandexon7genepolymorphismsandlungcancerriskanupdatedmetaanalysisandreview AT qianqian cyp1a1mspiandexon7genepolymorphismsandlungcancerriskanupdatedmetaanalysisandreview AT weishuzhen cyp1a1mspiandexon7genepolymorphismsandlungcancerriskanupdatedmetaanalysisandreview AT yulike cyp1a1mspiandexon7genepolymorphismsandlungcancerriskanupdatedmetaanalysisandreview |